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Alternative translation initiation is a mechanism whereby functionally altered proteins are pro-
duced from a single mRNA. Internal initiation of translation generates N-terminally truncated pro-
tein isoforms, but such isoforms observed in immunoblot analysis are often overlooked or
dismissed as degradation products. We identiﬁed an N-terminally truncated isoform of human
Dok-1 with N-terminal acetylation as seen in the wild-type. This Dok-1 isoform exhibited distinct
perinuclear localization whereas the wild-type protein was distributed throughout the cytoplasm.
Targeted analysis of blocked N-terminal peptides provides rapid identiﬁcation of protein isoforms
and could be widely applied for the general evaluation of perplexing immunoblot bands.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Protein isoforms generated through alternative translation ini-
tiation have been known for more than two decades, and they
appear to have important functions that are distinct from their
more extensively characterized wild-type counterparts [1–6].
N-terminal truncation resulting from alternative translation initi-
ation via a mechanism such as leaky scanning can inﬂuence pro-
tein subcellular localization and lead to formation of distinct
protein complexes, or promote speciﬁc interactions with proteins
or other molecules. Despite the recent dramatic increase in atten-
tion given to the ﬁeld of proteomics following completion of the
genome project and the development of mass spectrometry for
protein characterization, these isoforms have received little atten-
tion in typical proteomic studies. Perhaps this is because the N-
terminal peptides are not routinely detected in high throughput
proteomic analysis without explicit targeting. These truncated
isoforms are readily detectable as faster migrating bands in
SDS–PAGE and possible isoforms are frequently observed in
immunoblot analysis, but they have largely been dismissed aschemical Societies. Published by E
hi).
himurayama-shi, Tokyo 208-degradation products of wild-type proteins. On the other hand,
it is reported that at least 80% of eukaryotic cellular proteins
are N-terminally blocked [7]. Additionally, the most commonly
found N-terminal modiﬁcation is cotranslational Na-acetylation
of nascent polypeptides.
Human p62dok (also called Dok-1) [8,9] was ﬁrst identiﬁed as a
tyrosine-phosphorylated 62 kDa protein in transformed and
growth factor stimulated cells and is associated with RasGAP [8].
P62dok is constitutively tyrosine-phosphorylated in hematopoietic
progenitor cells isolated from chronic myelogenous leukemia
patients [9]. An isoform was found in T and B cells as C-terminally
truncated protein, p22Dokdel that is generated via alternative splic-
ing [10]. Another C-terminally truncated isoform discovered in a
chronic lymphocytic leukemia patient was determined to be
caused by a frameshift mutation [11]. In both cases, the PH domain
of Dok-1 was retained.
Here we report on an N-terminally truncated Dok-1 isoform
that exhibits a unique subcellular localization. We also report for
the ﬁrst time the identiﬁcation of an N-terminally truncated iso-
form generated via alternative translation initiation that receives
the same protein modiﬁcation as the wild-type. Targeting blocked
N-terminal peptides for mass spectrometry proved a very efﬁcient
strategy for rapid determination of the translation initiation site in
the investigation we report here, and we therefore suggest that the
strategy could be applied to facilitate the study of other proteins, as
well.lsevier B.V. All rights reserved.
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2.1. Cell lines
Leukemia cell line (K562), pancreatic cancer cell lines
(MIAPaCa-2, SU86.86, PANC-1, AsPC-1, BxPC-3, Capan-1), colon
cancer cell lines (RKO), malignant glioma cell line (U87-MG), and
ﬁbroblasts (IMR-90, WI-38) were obtained from ATCC. Malignant
glioma cell line U373-MG was obtained from Sigma. Pancreatic
cancer cell lines (PANC-3, PANC-28, and PANC-48) were gifted by
Dr. Li and lung cancer cell line (H226) and its brain metastasis in
mouse (H226Br) were gifted by Dr. Herbst, both of MD Anderson
Cancer Center. The human Mo7 megakaryoblastic leukemic cell
line previously described [9] was maintained in our lab in
RPMI1640 containing 10 ng/ml IL-3 (PeproTech EC). P210Bcr-Abl
expressing Mo7 cell line was established in our lab via retroviral
transduction as also previously described [12].2.2. Immunoblot analysis and antibodies
Whole cell extracts were prepared using lysis buffer (50 mM
Tris–HCl, pH 7.6, 150 mM NaCl, 5 mM EDTA, 1 mM EGTA, 1%Triton
X-100, 0.1 lg/ml aprotinin, 0.5 lg/ml leupeptin, 100 lg/ml PMSF,
1 mM Na3VO4, 1 mM NaF and 100 lM PAO). Cellular debris was re-
moved by centrifugation at 14,000g for 30 min at 4 C. Samples
were mixed with Laemmli’s loading buffer, boiled for 5 min, and
subjected to SDS–PAGE. 50 lg of protein from each cell line was
separated by SDS–PAGE (Criterion 4–15% gradient gel, BioRad).
Proteins were then transferred to PVDF membrane (Immobilon-P,
Millipore) and probed with speciﬁc antibodies. Anti-Dok-1 poly-
clonal antibody [9], anti-myc-tag monoclonal antibody (4A6, Milli-
pore), anti-pTyr monoclonal antibody (4G10, Millipore) and anti-
beta-actin (A-5441, Sigma) were used for detection. SuperSignal
West Pico chemiluminescent substrate (Pierce) was used for
immunoblot analysis.2.3. LC-MS/MS analysis
Mass spectrometric analysis was performed using an electro-
spray ion-trap mass spectrometer (LTQ, ThermoElectron). Solvents
used for LC-MS/MS analysis were all HPLC grade from Burdick &
Jackson. Modiﬁed trypsin (Promega) was used for in-gel digestion.
The peptides were separated by nano-LC (UltiMate, LC-Packings-
Dionex) using a C18 column (PepMap 75 lm  150 mm, LC-Pac-
kings) and eluted into the LTQ by an increasing gradient of aceto-
nitrile containing 0.01%TFA. The mass spectra were searched
against the NCBI database using Mascot (ver. 2.1.03) or SEQUEST
(Bioworks 3.1).β-actin
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Fig. 1. Immunoblot analysis of human cell lines using anti-Dok1 antibody. Lane 1 is a leu
in mouse; lanes 4–12 are pancreatic cancer lines; lane 13 is a colon cancer line; lanes 14
p44dok bands are indicated. Antibody epitope is illustrated in Fig. 2.2.4. Isolation of the blocked N-terminal peptide of p44dok
The 44 kDa proteins in cell lysates of the C-myc dok-1Mo7 cells
were enriched on immobilized anti-myc tag antibody (ProFound c-
Myc TagIP/Co-IP kit, Pierce) and eluted with myc-tag peptide
(100 lg/ml) in 25 mM Tris–HCl containing 150 mM NaCl (pH
7.2). The eluted proteins were denatured for 10 min at 80 C in
50 lL of the digestion buffer prior to protease treatment. The
digestion was performed using either Lys-N (Sigma) or modiﬁed
trypsin overnight at 37 C. The digest was then mixed with isothi-
ocyanato-glass and incubated for 3 h at 50 C. The reaction mixture
was ﬁltered with an ultrafreeMC ﬁlter (0.22 lm, Millipore). The
ﬂow-through fraction from the isothiocyanato-glass bead was
desalted using a ZipTip-C18 (Millipore) and analyzed by nanoLC-
MS/MS.
2.5. Immunoﬂuorescence study
Three cell lines, Mo7p210Bcr-Abl, Mo7p210Bcr-Ablp62dok, and
Mo7p210Bcr-Ablp44dok, were cultured in RPMI1640 containing 10%
fetal bovine serum (Hyclone). Approximately 5  104 cells were
washed with PBS and applied to slides using a Cytospin (Mod-
el7620 Cytocentrifuge, Wesco). The cells were ﬁxed in cold meth-
anol for 10 min at 20 C and permeabilized for 10 min at room
temperature with 0.2% TritonX-100. After blocking with 5% bovine
serum albumin (Sigma) in PBS for 30 min, the samples were
probed with AlexaFluor488 conjugated anti-myc-tag monoclonal
antibody (9B11, Cell Signaling) at room temperature for 2 h. The
slides were washed with PBS and water, and mounted with Vecta-
shield (Vector Laboratories). Images were taken using a confocal
microscopy (Nikon D-Eclipse C1) under 60 magniﬁcation and
analyzed using imaging software EZ-C1 3.40 (Nikon).
3. Results
3.1. Immunoblot analysis of human cell lines using anti-Dok-1
antibody
As shown in Fig. 1, immunoblot analysis using Dok-1 speciﬁc
antibody revealed 44 kDa major bands in addition to the band
for wild-type p62dok for the bulk of the cell lines. We refer to this
protein isoform as p44dok.
3.2. Sequence analysis of the lower molecular weight protein observed
in immunoblot analysis
Extensive LC-MS/MS analysis of the 44 kDa band revealed that
it is essentially the C-terminal half region of p62dok (Fig. 2). How-
ever, Edman degradation (Procise474, Applied Biosystems) of thep62dok
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kemia line; lanes 2 and 3 are respectively a lung cancer line and its brain metastasis
and 15 are malignant glioma lines, and lanes 16 and 17 are ﬁbroblasts. P62dok and
Fig. 2. LC-MS/MS of p44dok and schematic diagram for comparison of p62dok and p44dok. The amino acid sequence of Dok-1 is shown (top panel) and matching peptide hits
from LC-MS/MS analysis of p44dok are indicated in red. The p44dok sequence begins at Met-140 of the Dok-1 sequence. The hooked arrows indicate translation initiation sites
for p62dok and p44dok. All Met residues are underlined. The blocked N-terminal peptides identiﬁed in LC-MS/MS are indicated by the blue underline. Epitope sequence
recognized by Dok-1 antibody is boxed and indicated by an arrow. N-termini of both p62dok and p44dok are acetylated. The PH and PTB domains are indicated (bottom panel),
as well as residue numbers. The Dok-1 antibody recognition site is indicated by the inverted Y symbol.
R. Kobayashi et al. / FEBS Letters 583 (2009) 2441–2445 244344 kDa protein was unsuccessful. Furthermore, we were unable to
detect (data not shown) the missing N-terminal domain fragment
by immunoblot analysis using a Dok-1 PH domain speciﬁc anti-
body (kindly gifted from Dr. Van Aelst, Cold Spring Harbor Labora-
tory). This result led us to speculate that this protein was perhaps
not a degradation product and might also be N-terminally blocked.
We therefore isolated the N-terminal peptides of the potentially
blocked p44dok protein for mass spectrometric analysis using our
previously described method [13]. We were able to identify the
acetylated N-terminal peptide of p62dok (Supplementary Fig. 1A);
however, the blocked N-terminal peptide of p44dok was not detect-
able using the Lys-N digestion approach. Subdigestion of the N-ter-
minal fraction using endoproteinase Glu-C indicated a potential N-
terminal fragment but did not provide a deﬁnitive answer. We
were ﬁnally able to identify acetylated-MLENSLYSPT-
WEGSQFWVTVQR as an N-terminal fragment of the 44 kDa protein
using trypsin digest (Supplementary Fig. 1B). Like the N-terminus
of p62dok, the N-terminal end of p44dok starts at an acetylated
Met; however, p44dok starts at the third methionine (Met-140) of
Dok-1 (Fig. 2). LC-MS/MS analysis of p44dok covered 88.9% of the
C-terminal region of the Dok-1 sequence from M-140 to T-481. Be-
cause the ﬁrst Lys located at downstream of M-140 is Lys-213, the
Lys-N digest of p44dok produced a 74 amino acid-long peptide. This
peptide was too large for MS/MS analysis. We also found that
p44dok lacked the Pleckstrin homology (PH) domain.
3.3. Insertion of myc-tag sequence after the ﬁrst AUG at 50-end
interferes with p44dok production
To test if a single cDNA produces the two forms of protein, we
expressed either N-myc-dok-1 or C-myc-dok-1 in Mo7p210Bcr-Ablcells from which we originally puriﬁed p62dok [9]. Because a single
dok-1 cDNA generated both p62dok and p44dok, the possibility of
alternative splicing as a mechanism of p44dok production was elim-
inated. Interestingly, when N-myc-dok-1 was expressed, the
44 kDa protein band was discernable than that of p62dok, whereas
when C-myc-dok-1 was expressed, the 44 kDa band appeared
much stronger than that of p62dok (Fig. 3). This ﬁnding suggests
that p44dok is a product of alternative translation initiation, pre-
sumably by leaky scanning. We did not observe p44dok in immuno-
blot analysis of N-terminally myc-tagged Dok-1 expression using
antibody speciﬁc for the Dok-1 C-terminus epitope indicated in
Fig. 2, nor did immunoblot analysis using Dok-1 PH domain spe-
ciﬁc antibody detect any plausible bands for fragments containing
the N-terminal domain. We therefore eliminated proteolysis of
p62dok as a likely mechanism for production of p44dok. Addition-
ally, in vitro transcription/translation of Dok-1 cDNA using a rabbit
reticulocyte lysate cell free expression system (which does not
likely possess the same proteolytic pathways as intact human
cells) yields a pattern for production of p62dok and p44dok (Supple-
mentary Fig. 2) that is similar to that shown in Fig. 3.
3.4. Nucleotide sequence surrounding Met-140 has a much weaker
Kozak consensus sequence than Met-1
Alignment of nucleotide sequences surrounding all AUG codons
in dok-1 with the Kozak consensus sequence [14] is shown in Table
1. Selection of the initiation codon is generally determined by the
optimal Kozak consensus sequence GCC(A/G)CCAUGG with the
3 and +4 positions being the most inﬂuential. Interestingly, the
sequence surrounding AUG for Met-1 is an especially strong Kozak
consensus sequence match with G at the 3 and +4 positions. On
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Fig. 3. Location of myc-tag inﬂuences production of p44dok. P44dok was absent (or
substantially weaker) when myc-tag was added to N-terminus (N-myc) in
immunoblot analysis using anti-Dok-1 antibody (lanes 2 and 5). In contrast, when
myc-tag was added at the C-terminus (C-myc), the p44dok proteins were expressed
much more abundantly than p62dok (lanes 3 and 6) while p62dok production was
reduced. Vector refers to the vector only.
Table 1
Alignment of nucleotides surrounding all AUG codons in dok-1 with the Kozak
consensus sequence. The most inﬂuential positions, 3 and +4 are highlighted in
boldface.
Kozak: GCCACCAUGG
G
Met-1 GGGGCCAUGG
Met-6 GCAGUGAUGG
Met-140 CUGGAGAUGC
Met-215 AAGGUCAUGU
2444 R. Kobayashi et al. / FEBS Letters 583 (2009) 2441–2445the other hand, the sequence surrounding Met-140 is suboptimal.
As is evident in Fig. 3, p44dok is produced in much greater abun-
dance relative to p62dok, contrasting the expression levels that
would be expected based on the comparative strength of the asso-
ciated Kozak sequences.
3.5. Subcellular localization
Since it has been reported that the PH domain of recombinant
p62dok is necessary for localization to membranes [15], we
expected that p44dok would likely not migrate to the plasma mem-
brane. We used cell lines expressing either N-myc-Dok-1 or N-blot: 
anti-myc 
beta-actin
p62
p44
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ba 
Fig. 4. P44dok has distinct subcellular localization compared to p62dok. (A) Immunoﬂuor
tag antibody with AlexaFluor488 in Mo7p210Bcr-Abl cells. P44dok exhibited marked pe
cytoplasm (b). Mo7p210Bcr-Abl cells (vector only) were used as a control for background ﬂ
(B) Immunoblot analysis of the cell lines used for immunoﬂuorescent study. The left pan
anti-Dok-1 antibody. Lanes 1 and 4 are N-myc-p44dok expressing Mo7p210Bcr-Abl cells, la
the vector control. Only myc-tagged protein bands appear in lanes 1 and 2 whereas en
tagged proteins detected in lanes 1 and 2.myc-p44dok to analyze the subcellular localization patterns of the
different protein isoforms. Very interestingly, p44dok exhibited per-
inuclear localization, whereas p62dok was more broadly distributed
throughout the cytoplasm (Fig. 4).
4. Discussion
Protein isoforms produced through alternative translation initi-
ation are probably identiﬁed much less frequently than their actual
occurrence in nature despite their potential functional importance
and inﬂuence in biological systems. It is well known that most hu-
man cellular proteins are naturally N-terminally blocked. In this
study, we identiﬁed a new p62dokisoform, p44dok that was pro-
duced via alternative translation initiation. The N-terminal trunca-
tion that yields p44dok results in speciﬁc localization of the isoform
within the perinuclear region. In immunoblot analysis, the isoform
p44dok appeared to be ubiquitously expressed (Fig. 1); however,
the role of the isoform is currently unknown. As we demonstrate
in this report, targeting blocked N-terminal peptide provides a
straightforward approach for identifying previously overlooked
protein isoforms. We also found that p44dok and p62dok have the
same posttranslational modiﬁcation – acetylation – at their respec-
tive N-termini.
Although some proteins are subject to regulated degradation
through the N-end rule pathway [16], it is unlikely that such pro-
cessing leads to the formation of p44dok, since the truncated iso-
form is produced both in vivo as well as in the in vitro cell free
transcription/translation system used in this study. In contrast,
the acetylated N-terminal Met of p44dok (and p62dok) is consistent
with known cotranslational N-terminal processing that is con-
served in eukaryotes [17] wherein N-terminal methionines remain
if the penultimate residue is Asp or Leu (as is the case for p62dok
and p44dok, respectively). Na-acetyltransferase anchors to the ribo-
some and interacts with nascent polypeptides while they are with-
in 20–50 amino acids in length [17,18]. N-terminal acetylation is
almost exclusively found to occur cotranslationally, and Na-acety-
lation following translation has been reported only in the particu-
lar case of short peptides such as a-melanocyte-stimulating
hormone (13 residues) [19], leading us to postulate that acetyla-
tion of p44dok most likely occurs cotranslationally. The Na-acetyla-
tion of N-terminally truncated proteins could be common feature
to isoforms generated via alternative translation initiation – and
possibly alternative splicing, as well. This appears to be the ﬁrst di-
rect evidence of this phenomenon.blot: 
anti-Dok-1 
dok 
dok 
4        5        6 
beta-actin
c
escent study. N-myc-p44dok (a) or N-myc-p62dok (b) was visualized using anti-myc
rinuclear localization (a), whereas the wild-type was distributed throughout the
uorescence (c). Similar results were obtained in at least three separate experiments.
el shows immunoblot using anti-myc antibody and the right panel shows that with
nes 2 and 5 are N-myc-p62dok expressing Mo7p210Bcr-Abl cells, and lanes 3 and 6 are
dogenous p62dok and p44dok are also detected in lanes 4–6 in addition to the myc-
R. Kobayashi et al. / FEBS Letters 583 (2009) 2441–2445 2445Insertion of the N-terminal myc-tag sequence following the ﬁrst
AUG appears to interfere with the ribosomal scanning, resulting in
attenuation of translation initiation at the third AUG for Met-140
(Fig. 3), and a concomitant reduction in the production of p44dok.
A possible explanation for this is that the mechanism of alternative
initiation for p44dok production is leaky scanning caused by the
second AUG (Met-6) being located in close proximity (12 nucleo-
tides) to the ﬁrst AUG. Considering that a single ribosome contacts
approximately 30 nucleotides of the mRNA during translation, it is
conceivable that these proximate AUGs cause ribosome wobbling
that impedes normal translation, but that ribosomal subunits that
continue scanning downstream reach third AUG are able to
successfully initiate translation. Insertion of the myc-tag sequence
(33 nucleotides) between the ﬁrst two AUGs creates additional
space for assembly of the initiation complex at the ﬁrst AUG and
could thus stabilize recognition of the initiation site, resulting in
a preclusion of downstream alternative initiation that leads to
p44dok production. In other studies, more stable initiation at a ﬁrst
AUG was reported [20,21] when it was moved away from a nearby
second AUG.
In contrast to previously discovered Dok-1 isoforms, p44dok
lacks a PH domain but preserves the RasGAP binding sites [22]. It
has been reported that Dok-1 inhibits PDGF-induced mitogenesis
and has a role as a tumor suppressor [23]. Recently, Dok-1 was
found to be involved in diet-induced adipocyte hypertrophy and
obesity [24]. Dok-1 appears to be involved in a number of other
diverse biological functions.
N-terminally truncated isoforms can be generated through
mechanisms including alternative translation initiation or alterna-
tive splicing. Like alternative splicing [25], alternative translation
initiation may play a vital role in regulation and control by yielding
protein variants that are linked to a distinct biological functionality
and that help to maintain the ﬁdelity of biological systems.
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